The first reactive vaccination campaign against hepatitis E
Lancet Infect Dis
.
2022 Aug;22(8):1110-1111.
doi: 10.1016/S1473-3099(22)00421-2.
Authors
Iza Ciglenecki
1
,
John Rumunu
2
,
Joseph F Wamala
3
,
Patrick Nkemenang
4
,
Jetske Duncker
4
,
Robin Nesbitt
5
,
Etienne Gignoux
5
,
Trish Newport
6
,
Melat Heile
6
,
Christine Jamet
6
,
Monica Rull
6
,
Andrew S Azman
7
Affiliations
1
Médecins Sans Frontières, 1202 Geneva, Switzerland. Electronic address:
[email protected]
.
2
Ministry of Public Health, Juba, South Sudan.
3
World Health Organization, Juba, South Sudan.
4
Médecins Sans Frontières, Juba, South Sudan.
5
Epicentre, Paris, France.
6
Médecins Sans Frontières, 1202 Geneva, Switzerland.
7
Médecins Sans Frontières, 1202 Geneva, Switzerland; John Hopkins University, Baltimore, MD, USA.
PMID:
35870452
DOI:
10.1016/S1473-3099(22)00421-2
No abstract available
Publication types
Letter
MeSH terms
Hepatitis B Vaccines
Hepatitis E* / epidemiology
Hepatitis E* / prevention & control
Humans
Immunization Programs
Vaccination
Substances
Hepatitis B Vaccines
Grants and funding
001/WHO_/World Health Organization/International